Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP2257544

CRYSTALLINE FORMS AND TWO SOLVATED FORMS OF 4-AMINO-5-FLUORO-3-[5-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]QUINOLIN-2(1H)-ONE LACTIC ACID SALTS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    18.3.2009
  • EP published:
    3.12.2014
  • EP application number:
    09721534.7
  • Max expiry date:
    17.3.2029
  • Title:
    CRYSTALLINE FORMS AND TWO SOLVATED FORMS OF 4-AMINO-5-FLUORO-3-[5-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]QUINOLIN-2(1H)-ONE LACTIC ACID SALTS

Timeline

Today
18.3.2009EP application
3.12.2014EP Publication

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, 4056, Basel, CH

Inventor

  • Name:
    GIRON, Danielle
  • Address:
    Mulhouse, FR
  • Name:
    HAMMERSCHMIDT, Walter
  • Address:
    Basel, CH
  • Name:
    PIECHON, Philippe
  • Address:
    St. Louis, FR
  • Name:
    POLASEK, Johanne
  • Address:
    Plan les ouates, CH
  • Name:
    SCHREINER, Andreas
  • Address:
    Rheinfelden, CH
  • Name:
    STOWASSER, Frank
  • Address:
    Murg, DE

Priority

  • Number:
    37746 P
  • Date:
    19.3.2008
  • Country:
    US

Classification

  • Categories:
    C07D 401/14, A61K 31/496, A61P 35/00

Upload documents